Examination of PBRSO method for clinical models of hyperventilation syndrome

Examination of PBRSO method for clinical models of hyperventilation syndrome - PBRSO for hyperventilation syndrome

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022195

Enrollment

Registered

2016-05-03

Start date

2016-04-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperventilation syndrome

Interventions

To try 2 kinds of PBR methods after HVS PBR therapy for 5 minutes

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Healthy adults

Exclusion criteria

Exclusion criteria: Cerebral vascular disease Pulmonary dysfunction Heart failure Other severe disease

Design outcomes

Primary

Measure	Time frame
Comparison of effectiveness by checking disappearance rate of HVS symptoms such as numbness and lightheadedness between PBR therapy using paper bag and PBRSO therapy using plastic bag for 5 minutes respectively	—

Secondary

Measure	Time frame
Comparison of effectiveness represented by EtCO2 recovering above 30 mmHg between in PBR therapy using paper bag and in PBRSO therapy using plastic bag for 5 minutes respectively Confirmation of safety represented by SpO2 keeping above 95% in PBR therapy using paper bag and in PBRSO therapy using plastic bag for 5 minutes respectively	—

Countries

Japan

Contacts

Public ContactMasanobu Kishikawa

Fukuoka City Hospital Department of Emergency and Critical care medicine

kishikawam@aqr.bbiq.jp092-522-2846

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026